AbbVie Down Over 15%, on Pace for Record Percent Decrease -- Data Talk
June 25 2019 - 11:13AM
Dow Jones News
AbbVie Inc. (ABBV) is currently at $66.43, down $12.02 or
15.32%
-- Would be lowest close since May 31, 2017, when it closed at
$66.02
-- Would be largest percent decrease on record (Based on
available data back to Dec. 10, 2012)
-- Earlier Tuesday, AbbVie Inc. agreed to buy Allergan PLC for
about $63 billion. The takeover is worth about $188 a share in cash
and stock, the companies said in a statement
-- Worst two day stretch on record (Based on available data back
to Dec. 10, 2012)
-- Down 13.39% month-to-date; on pace for worst month since
October 2018 when it fell 17.69%
-- Down 27.94% year-to-date
-- Down 46.08% from its all-time closing high of $123.21 on Jan.
26, 2018
-- Down 27.88% from 52 weeks ago (June 26, 2018), when it closed
at $92.12
-- Down 32.79% from its 52 week closing high of $98.84 on July
10, 2018
-- Would be a new 52 week closing low
-- Traded as low as $66.29; lowest intraday level since June 1,
2017, when it hit $66.12
-- Down 15.5% at today's intraday low; largest intraday percent
decrease since Oct. 22, 2015, when it fell as much as 15.57%
-- Worst performer in the S&P 500 today
-- Most active stock in the S&P 500 today
All data as of 10:37:00 AM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 25, 2019 10:58 ET (14:58 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2024 to May 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From May 2023 to May 2024